BSX - Boston Scientific Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 560.3B
Enterprise Value 369.98B
Trailing P/E 43.73
Forward P/E 124.18
PEG Ratio (5 yr expected) 12.41
Price/Sales (ttm)5.98
Price/Book (mrq)6.39
Enterprise Value/Revenue 36.95
Enterprise Value/EBITDA 626.02

Trading Information

Stock Price History

Beta (3Y Monthly) 0.70
52-Week Change 312.14%
S&P500 52-Week Change 32.99%
52 Week High 343.84
52 Week Low 331.56
50-Day Moving Average 342.32
200-Day Moving Average 340.16

Share Statistics

Avg Vol (3 month) 35.56M
Avg Vol (10 day) 35.09M
Shares Outstanding 51.39B
Float 1.39B
% Held by Insiders 10.25%
% Held by Institutions 193.40%
Shares Short (Aug 15, 2019) 413.87M
Short Ratio (Aug 15, 2019) 42.51
Short % of Float (Aug 15, 2019) 41.12%
Short % of Shares Outstanding (Aug 15, 2019) 41.00%
Shares Short (prior month Jul 15, 2019) 415.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Nov 6, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 13.85%
Operating Margin (ttm)17.44%

Management Effectiveness

Return on Assets (ttm)5.00%
Return on Equity (ttm)16.26%

Income Statement

Revenue (ttm)10.08B
Revenue Per Share (ttm)7.27
Quarterly Revenue Growth (yoy)5.70%
Gross Profit (ttm)6.99B
EBITDA 2.69B
Net Income Avi to Common (ttm)1.4B
Diluted EPS (ttm)0.99
Quarterly Earnings Growth (yoy)-72.30%

Balance Sheet

Total Cash (mrq)123M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)9.8B
Total Debt/Equity (mrq)103.99
Current Ratio (mrq)1.31
Book Value Per Share (mrq)6.77

Cash Flow Statement

Operating Cash Flow (ttm)1.16B
Levered Free Cash Flow (ttm)-1.07B